We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zacks.com featured highlights include Globus Medical, NetApp and Assurant
Read MoreHide Full Article
For Immediate Release
Chicago, IL – September 10, 2026 – Stocks in this week’s article are Globus Medical, Inc. (GMED - Free Report) , NetApp, Inc. (NTAP - Free Report) and Assurant Inc. (AIZ - Free Report) .
3 Sales Growth Stocks to Buy Amid Renewed Mideast Tensions
U.S. equities have posted solid gains so far this year despite periodic volatility. Fed policy uncertainty, elevated Treasury yields, renewed Middle East tension, rising oil prices, persistent inflation, tariff concerns and stretched technology valuations have weighed on sentiment. Still, resilient corporate earnings and continued robust investment in AI have provided meaningful support to the market, helping major U.S. indexes remain firmly in positive territory in 2026.
Against this backdrop, the traditional approach to stock selection remains a good idea. Sales growth provides a more reliable basis for evaluating stocks compared with earnings-focused metrics. In this regard, stocks like Globus Medical, Inc., NetApp, Inc. and Assurant Inc. are worth buying.
Sales growth is a key indicator of a company’s underlying business strength, reflecting customer demand and its ability to sell products or services. Sustained revenue growth will likely signal favorable industry trends, market share gains, pricing power, successful product launches, or expansion into new markets and customer segments. Higher sales can also improve operating leverage by spreading fixed costs across a larger revenue base, supporting margin expansion and profitability.
However, revenue growth must be assessed alongside industry conditions, competitor performance, pricing trends, customer mix and the broader economy. Its quality also matters: recurring revenues, repeat purchases, volume-driven gains and resilient demand are generally more durable than temporary boosts. Companies that consistently generate high-quality sales growth are often better positioned to produce stable cash flows, fund expansion, strengthen competitive advantages and deliver sustainable shareholder returns. You can see the complete list of today’s Zacks #1 Rank stocks here.
3 Stocks With Strong Sales Growth to Buy
Based in Audubon, PA, Globus Medical is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. GMED has sales operations across 65 countries and sells through a mix of direct sales representatives and independent distributors.
GMED’s expected sales growth rate for 2026 is 8.8%. Globus Medical sports a Zacks Rank #1 at present.
Based in San Jose, CA, NetApp provides enterprise storage as well as data management software and hardware products and services. NTAP assists enterprises in managing multiple cloud environments, adopting next-generation technologies like AI, Kubernetes and contemporary databases, and navigating the complexity brought about by the development of data and cloud usage.
NTAP’s expected sales growth rate for fiscal 2027 is 18.6%. NetApp currently carries a Zacks Rank #2.
Headquartered in New York, Assurant is a global provider of risk management solutions in the housing and lifestyle markets. AIZ safeguards and services connected devices, homes, automobiles and commercial equipment in partnership with leading brands.
Assurant’s sales are expected to rise 8.5% in 2026. AIZ carries a Zacks Rank #2 at present.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.
View the Zacks #1 Rank List
Image: Bigstock
Zacks.com featured highlights include Globus Medical, NetApp and Assurant
For Immediate Release
Chicago, IL – September 10, 2026 – Stocks in this week’s article are Globus Medical, Inc. (GMED - Free Report) , NetApp, Inc. (NTAP - Free Report) and Assurant Inc. (AIZ - Free Report) .
3 Sales Growth Stocks to Buy Amid Renewed Mideast Tensions
U.S. equities have posted solid gains so far this year despite periodic volatility. Fed policy uncertainty, elevated Treasury yields, renewed Middle East tension, rising oil prices, persistent inflation, tariff concerns and stretched technology valuations have weighed on sentiment. Still, resilient corporate earnings and continued robust investment in AI have provided meaningful support to the market, helping major U.S. indexes remain firmly in positive territory in 2026.
Against this backdrop, the traditional approach to stock selection remains a good idea. Sales growth provides a more reliable basis for evaluating stocks compared with earnings-focused metrics. In this regard, stocks like Globus Medical, Inc., NetApp, Inc. and Assurant Inc. are worth buying.
Sales growth is a key indicator of a company’s underlying business strength, reflecting customer demand and its ability to sell products or services. Sustained revenue growth will likely signal favorable industry trends, market share gains, pricing power, successful product launches, or expansion into new markets and customer segments. Higher sales can also improve operating leverage by spreading fixed costs across a larger revenue base, supporting margin expansion and profitability.
However, revenue growth must be assessed alongside industry conditions, competitor performance, pricing trends, customer mix and the broader economy. Its quality also matters: recurring revenues, repeat purchases, volume-driven gains and resilient demand are generally more durable than temporary boosts. Companies that consistently generate high-quality sales growth are often better positioned to produce stable cash flows, fund expansion, strengthen competitive advantages and deliver sustainable shareholder returns. You can see the complete list of today’s Zacks #1 Rank stocks here.
3 Stocks With Strong Sales Growth to Buy
Based in Audubon, PA, Globus Medical is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. GMED has sales operations across 65 countries and sells through a mix of direct sales representatives and independent distributors.
GMED’s expected sales growth rate for 2026 is 8.8%. Globus Medical sports a Zacks Rank #1 at present.
Based in San Jose, CA, NetApp provides enterprise storage as well as data management software and hardware products and services. NTAP assists enterprises in managing multiple cloud environments, adopting next-generation technologies like AI, Kubernetes and contemporary databases, and navigating the complexity brought about by the development of data and cloud usage.
NTAP’s expected sales growth rate for fiscal 2027 is 18.6%. NetApp currently carries a Zacks Rank #2.
Headquartered in New York, Assurant is a global provider of risk management solutions in the housing and lifestyle markets. AIZ safeguards and services connected devices, homes, automobiles and commercial equipment in partnership with leading brands.
Assurant’s sales are expected to rise 8.5% in 2026. AIZ carries a Zacks Rank #2 at present.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners Up
For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2986806/3-sales-growth-stocks-to-buy-amid-renewed-middle-east-tensions
Follow us on Twitter: https://www.twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Contact: Jim Giaquinto
Company: Zacks.com
Phone: 312-265-9268
Email: pr@zacks.com
Visit: https://www.zacks.com/
Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.